D-0246-2025 Class II
FDA drug recall D-0246-2025 was initiated by Padagis US LLC on Feb 6, 2025 and is designated Class II. Reason for recall: Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product. Affected quantity: 4944 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 5, 2025
- Initiation Date
- Feb 6, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4944 cartons
Product description
Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30
Reason for recall
Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.
Distribution pattern
Nationwide in the USA
Code information
Lot # 193109; Exp. 07/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0246-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026